EW - Edwards Lifesciences Corp.

EW Stock Chart

EW Profile

Edwards Lifesciences Corporation operates as a leading provider of innovative medical products and technologies catering to structural heart disease, critical care, and surgical monitoring across global markets including the United States, Europe, Japan, and beyond. The company is renowned for its transcatheter heart valve replacement products, which enable minimally invasive procedures for patients needing heart valve replacements. Additionally, Edwards Lifesciences offers advanced transcatheter solutions for repairing and replacing mitral and tricuspid valves, enhancing treatment options for valve diseases.

Innovative products such as the PASCAL and Cardioband transcatheter valve repair systems underscore the company's commitment to advancing minimally invasive therapies. Complementing its portfolio, Edwards Lifesciences provides surgical structural heart solutions like the INSPIRIS aortic surgical valve and KONECT RESILIA, a pre-assembled aortic tissue valved conduit, addressing diverse patient needs for valve and aortic root replacements. The company also pioneers groundbreaking technologies such as the HARPOON Beating Heart Mitral Valve Repair System, tailored for patients with degenerative mitral regurgitation.

Beyond structural heart solutions, Edwards Lifesciences excels in critical care with its hemodynamic monitoring systems that assess heart function and fluid status in surgical and intensive care environments. Their Acumen Hypotension Prediction Index software is pivotal in alerting clinicians to potential hypotension risks, enhancing patient safety and proactive care management. The company's extensive product range is distributed globally through a direct sales force and independent distributors, reinforcing its broad market presence and accessibility.

Founded in 1958 and headquartered in Irvine, California, Edwards Lifesciences Corporation continues to drive innovation in cardiovascular care, delivering transformative technologies that improve patient outcomes and redefine standards in cardiac surgery and critical care monitoring worldwide.

EW Revenue Chart

EW Earnings

Analyst Ratings